Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aramchol in Subjects With Hepatic Impairment
Conditions
Interventions
Aramchol free acid tablet 600mg, single dose
Aramchol free acid tablet 300mg, bid
Locations
3
United States
Division of Clinical Pharmacology, University of Miami
Miami, Florida, United States
Orlando Clinical Research Center
Orlando, Florida, United States
Alliance for Multispecialty Research
Knoxville, Tennessee, United States
Start Date
February 13, 2020
Primary Completion Date
March 24, 2022
Completion Date
March 24, 2022
Last Updated
August 14, 2024
NCT07324616
NCT04271488
NCT06952634
NCT06841315
NCT06619054
NCT06813781
Lead Sponsor
Galmed Research and Development, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions